Detalhe da pesquisa
1.
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
Respir Res
; 25(1): 33, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238788
2.
Episodic Cost of Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus Among US Infants During the First Year of Life.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133638
3.
Clinical Impact of Severe Obesity in Patients with Lymphoedema.
Eur J Vasc Endovasc Surg
; 65(3): 406-413, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403939
4.
Under recognition and treatment of lymphedema in head and neck cancer survivors - a database study.
Support Care Cancer
; 31(4): 229, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952136
5.
Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease.
Curr Ther Res Clin Exp
; 98: 100696, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950457
6.
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 204(1): 74-81, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434107
7.
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice.
Support Care Cancer
; 29(4): 2179-2186, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32880732
8.
Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization.
Clin Infect Dis
; 68(11): 1831-1838, 2019 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239637
9.
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice.
BMC Cancer
; 19(1): 151, 2019 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30764783
10.
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study.
BMC Cancer
; 19(1): 792, 2019 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399079
11.
Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.
Chron Respir Dis
; 16: 1479973119839961, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961354
12.
Correction to: Under recognition and treatment of lymphedema in head and neck cancer survivors - a database study.
Support Care Cancer
; 31(6): 336, 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183200
13.
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis.
Respiration
; 96(4): 314-322, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025392
14.
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 196(9): 1162-1171, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28657784
15.
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.
Thorax
; 72(2): 148-153, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27708114
16.
Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.
Support Care Cancer
; 25(2): 439-447, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734153
17.
The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review.
Support Care Cancer
; 25(8): 2619-2629, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484882
18.
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
Respiration
; 93(6): 415-423, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28399537
19.
Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 194(6): 711-8, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26938706
20.
Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.
J Oncol Pharm Pract
; 23(1): 33-42, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568602